Mela Sciences (NSDQ:MELA) was warned by the NASDAQ Stock Market that it must pull its shares above $1.00 or risk being de-listed by the stock exchange.
Wall Street Beat
California spinal startup announces $3.6M IPO
Carlsbad, Calif.-based Aurora Spine is hoping to round up as much as $3.6 million through an initial public offering, launched today, through which the company is issuing nearly 5.2 million shares at a per-share price of 70¢.
Class action lawsuit accuses Biolase and officers of lying to investors
Texas spinal devices maker LDR Holding shoots for IPO of up to $69M
LDR Holding Corp. announced that it’s making a bid for its initial public offering, aiming to sell its stock on the NASDAQ global market under the stock ticker ‘LDRH’, according to a company statement.
The company Texas-based spinal device company did not disclose the number of shares or detailed pricing for the IPO, but filed for an offering of up to $69 million, SEC documents show.
Accuray touts another quarter of growth, gains Wall Street favor
Medtronic’s maneuvers may signal long-term struggles for industry
InVivo tanks on push-back for spinal injury trial
GPO: Premier eyes IPO worth up to $100M
Premier healthcare alliance is eying an initial public offering worth up to $100 million, according to documents filed this week with the SEC. The group purchasing organization has yet to release the number of shares or the final price range for the offering.
Abiomed jumps on massive VA order for Impella pumps
Echo Therapeutics rises on CEO Mooney’s sudden departure
Echo Therapeutics (NSDQ:ECTE) chairman, president & CEO Dr. Patrick Mooney handed back the keys to the corner office rather suddenly, the company announced today.
Clash between company and doc shakes HeartWare shares
Shares of HeartWare International (NSDQ:HTWR) are on watch in the wake of negative commentary from a Northland Capital Markets analyst.